Skip to content Skip to sidebar Skip to footer

Newsletter

Charlie Youlden

Charlie is an Associate Equity Research Analyst covering ASX small caps across technology, mining and industrials.

His investing journey began in 2020 with large-cap US technology stocks, before he went on to complete a Commerce degree in Finance and Marketing at UTS, the Wall Street Prep Financial Modelling course, and Columbia Business School’s Value Investing course.

Charlie’s goal is to make investing clear, digestible and genuinely useful for everyday retail investors, helping them make better decisions with more confidence.

667 articles published

Healthcare Stocks Tech Stocks Technology

Sigma Healthcare rerating rests on delivering $100m merger synergies

Sigma Healthcare (ASX: SIG) now turns on one fact above all others: the Chemist Warehouse merger has transformed a low-growth wholesaler into a scaled pharmacy retail and distribution group, and management has already lifted the expected synergy prize to $100m a year by FY29 from $60m. That upgrade, announced in October, was the clearest signal…

ByCharlie YouldenMarch 31, 20260Comments

Market news Tech Stocks Technology

Barossa cash flow now drives the Santos valuation debate

Barossa has now shipped its first LNG cargo through Darwin LNG, Pikka phase 1 is nearing first oil, and Santos (ASX: STO) has just approved a Cooper Basin optimisation project aimed at cutting costs and extending field life. That is the attraction. The tension is that energy prices remain cyclical, major projects still need to ramp…

ByCharlie YouldenMarch 31, 20260Comments

Tech Stocks Technology

Rio Tinto needs Pilbara cash flow to unlock copper and lithium value

Rio Tinto (ASX: RIO) enters 2026 with two opposing forces in plain sight: the Pilbara iron ore machine is still generating the bulk of cash, but the company is spending heavily to build a broader future through Oyu Tolgoi, Simandou and lithium. That tension matters because investors are trying to judge whether current cyclical pressure…

ByCharlie YouldenMarch 31, 20260Comments

Tech Stocks Technology

NEXTDC rerates on 296.8MW order book converting into billings through FY29

NEXTDC (ASX: NXT) has moved sharply higher after a run of announcements that changed how much future capacity investors can reasonably expect the company to monetise. The biggest trigger was the 25 February 2026 half-year result, when contracted utilisation jumped 137% to 416.6MW and the forward order book reached 296.8MW, with that capacity expected to convert…

ByCharlie YouldenMarch 31, 20260Comments

Tech Stocks Technology

IperionX valuation now hinges on Virginia converting prototypes into repeat orders

IperionX (ASX: IPX) now has its Virginia titanium manufacturing campus online, government funding largely locked in, and a free transfer of about 290 metric tons of titanium scrap to feed current operations. That is the core tension in the stock today. The underlying asset base and strategic position look stronger than they did a year ago,…

ByCharlie YouldenMarch 31, 20260Comments

Mining Stocks

DevEx Resources needs 2026 drill hits to unlock its enlarged uranium footprint

DevEx Resources (ASX: DEV) has spent the past few months reshaping itself around one central asset theme: uranium ground in the Alligator Rivers Uranium Province, anchored by the Nabarlek Uranium Project and enlarged by two tenure deals struck in late 2025. That has come at a time when small-cap resource stocks are still dealing with…

ByCharlie YouldenMarch 31, 20260Comments

Tech Stocks Technology

Calix valuation turns on Bacchus Marsh revenue from Green360 tolling

Calix (ASX: CXL) has reached an important point because its valuation now rests less on distant decarbonisation promise and more on whether its existing assets can convert into repeatable revenue. The clearest recent example was the 23 March Green360 toll processing agreement, which allows Calix to process up to 30,000 tonnes a year of calcined clay…

ByCharlie YouldenMarch 31, 20260Comments

Tech Stocks Technology

Botanix (ASX: BOT) The Bleeding Has Stopped, Now Comes the Hard Part

Cash Burn Slowing, Execution Risk Rising Botanix announced an important update on its supplier payment terms, which gives investors much better visibility around the company’s cash runway. For many investors following the stock, cash burn has been one of the biggest concerns. That is why the recent placement at 6 cents per share came as such…

ByCharlie YouldenMarch 30, 20260Comments

Market news

The True Economic Cost of a US Iran War

America’s Iran War Bill Is Exploding An Iranian strike, likely involving a drone, appears to have damaged a US E-3 Sentry airborne warning and control aircraft at Prince Sultan Air Base in Saudi Arabia. Reports suggest the hit landed near the radar dome attachment point, which matters because the E-3 is not just a surveillance…

ByCharlie YouldenMarch 30, 20260Comments

Market news

ASX Opens Lower as Houthi Escalation Rekindles War Fears

Bab el-Mandeb Is the Real ASX Market Risk Over the weekend, the Houthis formally entered the current Iran-Israel-US conflict by launching their first direct attacks on Israel since the war began. The group reportedly fired missiles and later carried out a drone strike, saying the attacks were in response to strikes on Iran and allied…

ByCharlie YouldenMarch 30, 20260Comments